IP Library Granted Patent US 11,839,470
Granted Patent B2
US 11,839,470 · App. 17/576,281 · Granted Dec 12, 2023

Active-pulse blood analysis system

Inventors: Massi Joe E. Kiani (Laguna Niguel, CA); Mathew Paul (Irvine, CA); Jesse Chen (Foothill Ranch, CA); Marcelo M. Lamego (Cupertino, CA)
Assignee: MASIMO CORPORATION
A61B5/14552A61B5/6826A61B5/721A61B5/7207
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,839,470
App. No.
17/576,281
Granted
Dec 12, 2023
Kind
B2
Abstract

An active-pulse blood analysis system has an optical sensor that illuminates a tissue site with multiple wavelengths of optical radiation and outputs sensor signals responsive to the optical radiation after attenuation by pulsatile blood flow within the tissue site. A monitor communicates with the sensor signals and is responsive to arterial pulses within a first bandwidth and active pulses within a second bandwidth so as to generate arterial pulse ratios and active pulse ratios according to the wavelengths. An arterial calibration curve relates the arterial pulse ratios to a first arterial oxygen saturation value and an active pulse calibration curve relates the active pulse ratios to a second arterial oxygen saturation value. Decision logic outputs one of the first and second arterial oxygen saturation values based upon perfusion and signal quality.

Claims (42)

1. An active-pulse blood analysis system, comprising:

an optical emitter that that illuminates a tissue site with multiple wavelengths of optical radiation;

an optical sensor that outputs sensor signals responsive to the optical radiation after attenuation by pulsatile blood flow within the tissue site;

a monitor that receives the sensor signals and generates an arterial pulse ratio and an active pulse ratio according to the wavelengths;

one or more memory devices storing an arterial calibration curve that relates arterial pulse ratios to arterial oxygen saturation values (SpO2);

one or more memory devices storing an active pulse calibration curve that relates active pulse ratios to arterial oxygen saturation values (SpO2AP);

one or more processors configured to:

select a first arterial oxygen saturation value (SpO2) from the arterial calibration curve based on the arterial pulse ratio generated by the monitor, and

select a second arterial oxygen saturation value (SpO2AP) from the active pulse calibration curve based on the active pulse ratio generated by the monitor; and

a selection module that outputs a third arterial oxygen saturation value (SpO2M) selected from one of the first arterial oxygen saturation value (SpO2) and the second arterial oxygen saturation value (SpO2AP) based on a signal quality input and a perfusion index input.

2. The active-pulse blood analysis system according to claim 1 , wherein the third arterial oxygen saturation (SpO2M) is tolerant to at least one of motion, low perfusion and low signal quality.

3. The active-pulse blood analysis system according to claim 1 , wherein the signal quality input is a Boolean signal quality input (BSQ) and the perfusion index input is a Boolean perfusion index input (BPI).

4. The active-pulse blood analysis system according to claim 3 , wherein the selection module outputs the first arterial oxygen saturation only when the BSQ and the BPI are both equal to 1.

5. An active-pulse blood analysis method comprising:

inputting optical sensor data;

calculating arterial pulse ratios from the optical sensor data;

calculating active pulse ratios from the optical sensor data;

applying an arterial calibration curve stored in one or more memory devices to the arterial pulse ratios so as to generate an SpO2 parameter indicative of arterial oxygen saturation determined from an arterial pulse;

applying an active pulse calibration curve stored in one or more memory devices to the arterial pulse ratios so as to generate an SpO2AP parameter indicative of arterial oxygen saturation determined from an active pulse; and

choosing between the SpO2 parameter and the SpO2AP parameter so as to generate an SpO2M output parameter, the SpO2M output parameter comprising either the SpO2 parameter or the SpO2AP parameter, based on signal quality input.

6. The active-pulse blood analysis method according to claim 5 , wherein the SpO2M output parameter is indicative of an arterial oxygen saturation measurement tolerant to at least one of motion, low perfusion and low signal quality.

7. The active-pulse blood analysis method according to claim 5 , wherein choosing the signal quality input comprises a Boolean signal quality (BSI) and a Boolean perfusion index input (BPI).

8. The active-pulse blood analysis method according to claim 7 , further comprising measuring a perfusion index (PI), and wherein the Boolean perfusion input (BPI) is zero when the perfusion index (PI) is below a first threshold boundary.

9. The active-pulse blood analysis method according to claim 8 , further comprising measuring an acceleration of an optical sensor, and wherein the Boolean signal quality (BSQ) is zero when the measured acceleration is above a second threshold boundary.

10. The active-pulse blood analysis method according to claim 9 , wherein the second threshold boundary is an acceleration of 0.3 g.

11. The active-pulse blood analysis method according to claim 8 , wherein the first threshold boundary is a perfusion index (PI) of 1%.

12. An active-pulse blood analysis apparatus comprising:

an optical emitter means for transmitting multiple wavelengths of light into a tissue site;

an optical sensor means for detecting the transmitted light after attenuation by arterial blood flow and active pulsed blood flow within the tissue site so as to generate plethysmograph data;

a processor means for calculating an arterial pulse ratio from the plethysmograph data and an active pulse ratio from the plethysmograph data;

a means for storing:

an arterial calibration curve means for relating arterial pulse ratios to oxygen saturation values (SpO2); and

an active pulse calibration curve means for relating active pulse ratios to active pulse oxygen saturation values (SpO2AP);

a means for selecting:

an oxygen saturation value (SpO2) from the arterial calibration curve means based on the arterial pulse ratio; and

an active pulse oxygen saturation value (SpO2AP) from the active pulse calibration curve means based on the active pulse ratio; and

a means for selecting either the oxygen saturation value (SpO2) or the active pulse oxygen saturation value (SpO2AP) as an oxygen saturation value (SpO2M) based on a signal quality input and a perfusion index input.

13. The active-pulse blood analysis apparatus according to claim 12 , wherein the signal quality input is a Boolean signal quality (BSQ) and the perfusion index input is a Boolean perfusion index (BPI).

14. The active-pulse blood analysis apparatus of claim 13 , wherein the Boolean perfusion input (BPI) is zero when a measured perfusion index (PI) is below a first threshold boundary.

15. The active-pulse blood analysis apparatus according to claim 14 , wherein the first threshold boundary is a perfusion index (PI) of 1%.

16. The active-pulse blood analysis apparatus of claim 13 , wherein the Boolean signal quality input (BPI) is zero when a measured acceleration of the optical sensor is greater than a second threshold boundary.

17. The active-pulse blood analysis apparatus according to claim 16 , wherein the second threshold boundary is an acceleration of 0.3 g.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2023
From: KIANI, MASSI JOE E.; PAUL, MATHEW; CHEN, JESSE; LAMEGO, MARCELO M.
To: MASIMO CORPORATION
Reel/Frame 065121/0683 →
Continuity (7)
Continuation 16804507 · Feb 28, 2020
Continuation 15670405 · Aug 7, 2017
Continuation 14328694 · Jul 10, 2014
Continuation In Part 14153393 · Jan 13, 2014
Provisional Application 61844699 · Jul 10, 2013
Provisional Application 61752976 · Jan 16, 2013
Related Publication 20220133189A1 · May 5, 2022
Cited By (4)
US 12,193,813 US 12,458,295 US 12,629,067 US 12,648,723